Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CEPHALEXIN Cause Contraindicated product administered? 102 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 102 reports of Contraindicated product administered have been filed in association with CEPHALEXIN (Cephalexin). This represents 1.3% of all adverse event reports for CEPHALEXIN.

102
Reports of Contraindicated product administered with CEPHALEXIN
1.3%
of all CEPHALEXIN reports
0
Deaths
47
Hospitalizations

How Dangerous Is Contraindicated product administered From CEPHALEXIN?

Of the 102 reports, 47 (46.1%) required hospitalization, and 1 (1.0%) were considered life-threatening.

Is Contraindicated product administered Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CEPHALEXIN. However, 102 reports have been filed with the FAERS database.

What Other Side Effects Does CEPHALEXIN Cause?

Drug hypersensitivity (2,055) Rash (897) Diarrhoea (711) Dyspnoea (593) Drug ineffective (540) Nausea (521) Pruritus (499) Urticaria (404) Vomiting (393) Hypersensitivity (379)

What Other Drugs Cause Contraindicated product administered?

ABATACEPT (13,559) METHOTREXATE (13,121) ETANERCEPT (12,062) TOCILIZUMAB (11,547) ADALIMUMAB (11,270) LEFLUNOMIDE (11,206) HYDROXYCHLOROQUINE (10,557) RITUXIMAB (10,479) INFLIXIMAB (9,618) SULFASALAZINE (8,698)

Which CEPHALEXIN Alternatives Have Lower Contraindicated product administered Risk?

CEPHALEXIN vs CERITINIB CEPHALEXIN vs CERLIPONASE ALFA CEPHALEXIN vs CERTICAN CEPHALEXIN vs CERTOLIZUMAB CEPHALEXIN vs CERTOLIZUMAB PEGOL

Related Pages

CEPHALEXIN Full Profile All Contraindicated product administered Reports All Drugs Causing Contraindicated product administered CEPHALEXIN Demographics